Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort StudyNaomi J Patel, Kristin M D'Silva, Tiffany Y-T Hsu, et al.
ACR Open Rheumatology|December 10, 2021
Coronavirus Disease 2019 Outcomes Among Recipients of Anti-CD20 Monoclonal Antibodies for Immune-Mediated Diseases: A Comparative Cohort StudyNaomi J Patel, Kristin M D'Silva, Tiffany Y-T Hsu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 18, 2009
Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeabilityUwe Pfeil, Muhammad Aslam, Renate Paddenberg, et al.
Science (New York, N.Y.)|July 4, 2015
Heavy fermions. Unconventional Fermi surface in an insulating stateB S Tan, Y-T Hsu, B Zeng, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2022
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to OmicronYumeko Kawano, Naomi J Patel, Xiaosong Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective studyMichael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.
Pageof 7